Edgar Borges de Oliveira-Júnior

Clinical and Genotypic Spectrum of Chronic Granulomatous Disease in 71 Latin American Patients: First Report from the LASID Registry

Edgar Borges de Oliveira-Júnior, Nuria Bengala Zurro, Carolina Prando et al. · Pediatric Blood & Cancer · 2015 · 89 citations · Full text

Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance

Carmen Oleaga‐Quintas, Edgar Borges de Oliveira-Júnior, Jérémie Rosain et al. · Journal of Clinical Immunology · 2021 · 47 citations · Full text

Developmental Biology, Genetic Disorder, Genetics +7

BAY 41‐2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes

Paulo V. Soeiro-Pereira, Ângela Falcai, Edgar Borges de Oliveira-Júnior et al. · British Journal of Pharmacology · 2011 · 14 citations · Full text

Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells

Edgar Borges de Oliveira-Júnior, Sara M. Thomazzi, Jussara Rehder et al. · European Journal of Pharmacology · 2007 · 11 citations

Thp-1 Cells, Aldo-keto Reductase, Biochemistry +10

High‐Performance Liquid Chromatography Under Partially Denaturing Conditions (dHPLC) is a Fast and Cost‐Effective Method for Screening Molecular Defects: Four Novel Mutations Found in X‐Linked Chronic Granulomatous Disease

Edgar Borges de Oliveira-Júnior, Carolina Prando, Juan Antonio López et al. · Scandinavian Journal of Immunology · 2012 · 10 citations · Full text

Human Polymorphism, Diagnosis, Pathology +19